Date/Time
Date(s) - 17 Nov 2026
10:00 AM - 11:00 AM
Quantum Computing for Drug Discovery and Medicine:
Emerging Applications and Industry-Wide Opportunities
Tuesday, November 17, 2026
10:00 a.m. -11:00 a.m. AZ | 12:00 p.m.-1:00 p.m. EST | Virtual
NOTE: You will be required to establish a profile in the BioNJ system to register.
AZBio is pleased to share this opportunity with AZBio Members courtesy of BioNJ.
The discovery and development of new medicines remain among the most complex and resource-intensive challenges in healthcare. Quantum computing offers a fundamentally new approach to modeling molecular systems, with the potential to accelerate drug discovery beyond the capabilities of classical methods.
“Quantum Computing for Drug Discovery and Medicine: Emerging Applications and Industry-Wide Opportunities” provides an introduction to quantum computing — what it is, why it matters and how it works — followed by insights into IBM Quantum’s roadmap toward scalable, utility-driven systems.
Attendees will gain an overview of how quantum algorithms are being developed for applications in quantum chemistry and optimization, including emerging approaches to studying molecular interactions and identifying novel therapeutic candidates.
Through examples of industry collaborations and research initiatives, the session will illustrate how organizations are beginning to integrate quantum computing into innovation workflows today while preparing for larger-scale applications in the future. The talk concludes with a forward-looking perspective on how quantum computing could help shape the next generation of drug discovery and medicine across the broader industry.
This virtual session is designed for a broad audience across the healthcare, life sciences and technology sectors, including:
- Pharmaceutical & biotechnology professionals
- Startup innovators
- Academic researchers
- Healthcare organizations
- Computational scientists
- R&D leaders
- And business and technology strategists seeking to understand the practical and future implications of quantum computing.
No prior quantum computing expertise is required.
IBM Presenters:
Gopal Karemore, Ph.D.
Global Quantum Lead
Healthcare and Life Sciences
IBM Research
Dr. Karemore leads efforts to drive the adoption of quantum computing in life sciences and healthcare, working with IBM teams and external partners to deliver high-impact solutions. Prior to joining IBM, he held research and leadership roles at Novo Nordisk (Denmark), GE Research (India), Spanish National Centre for Cardiovascular Research (Spain), Danish Stem Cell Centre (Denmark), Novo Foundation Centre for Protein Research (Denmark), Fraunhofer Institute (Germany) and Penn Medicine (USA).
Don Grust, MS, MBA
Managing Director
QuantumToMarket
Mr. Grust is Managing Director of QuantumToMarket, an advisory firm that helps companies commercialize their technology. He began his career at Bell Labs before joining the early wireless industry to pioneer and commercialize mobile enterprise software. This led to a series of executive roles at early stage companies, including CEO of a successful venture-funded turnaround. Mr. Grust founded the Quantum Driven New Jersey Meetup, is helping to lead New Jersey’s initiative to develop a quantum strategy and is an active member of the Quantum Economic Development Consortium.
Register today for this complimentary virtual session on November 17 and discover how quantum computing is opening new possibilities for drug discovery, accelerating innovation and shaping the future of medicine. We look forward to having you join us!